Research compounds
Dabogratinib (TYRA-300)CAS 2800223-30-5
A selective FGFR3 research inhibitor for kinase studies.
Dabogratinib (TYRA-300) (CAS 2800223-30-5) is listed in the KALONANKH catalog for research, analysis or formulation development. Availability and supply terms require confirmation.
Documentation availability
Documentation is not available for every material. Please check what information is available for this product and batch before confirming your order.
Check for this materialCHEMICAL IDENTITY
- CAS
- 2800223-30-5
- Molecular formula
- C25H24Cl2N6O3S
- Molecular weight
- 559.47 g/mol
- Material family
- Research compounds
RESEARCH AREAS
Kinase signaling · FGFR3 biology · medicinal chemistry
Dabogratinib is a selective FGFR3 research inhibitor used to investigate kinase selectivity, resistance-associated variants and FGFR signaling.
IDENTITY NOTE
What was reviewed.
Name and CAS are consistent; positioned only in research-pathway language.
- Verified database status
- Identity verified
- Intended use
- Research, analysis, or formulation development.
Compare identities in this family
Records share a catalog family, not substitute status. Compare identity and research context before selecting a material.
| Material | CAS | Formula | Molecular weight | Research areas |
|---|---|---|---|---|
| Dabogratinib (TYRA-300)This record | 2800223-30-5 | C25H24Cl2N6O3S | 559.47 g/mol | Kinase signaling; FGFR3 biology; medicinal chemistry |
| 5-Deazaflavin | 26908-38-3 | C11H7N3O2 | 213.19 g/mol | Redox chemistry; enzyme cofactors; photochemistry |
| TND-1128 (3-Methyl-10-ethyl-5-deazaflavin) | 59997-14-7 | C14H13N3O2 | 255.27 g/mol | Redox cofactors; electron transfer; mitochondrial model systems |
| SRT2104 (GSK2245840) | 1093403-33-8 | C26H24N6O2S2 | 516.64 g/mol | Sirtuin biology; metabolism; inflammation models |
Material questions
What is the CAS number of Dabogratinib (TYRA-300)?
The CAS recorded in this catalog is 2800223-30-5. Review the identity note and chemical form before comparing suppliers.
What are its molecular formula and weight?
The recorded formula is C25H24Cl2N6O3S and the molecular weight is 559.47 g/mol. These describe chemical identity, not batch purity.
In which areas is Dabogratinib (TYRA-300) studied?
The recorded research areas are: Kinase signaling; FGFR3 biology; medicinal chemistry. These describe research contexts, not clinical indications or a guarantee of suitability for your project.
Not intended for human use, diagnosis, or treatment. Supply terms, tax information, and logistics are confirmed in the formal quotation.